ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016
Lapatinib in Gastric Cancer: What Is the LOGiCal Next Step?
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 23 citations in OpenAlex.
- A novel prognostic model based on migrasome-related LncRNAs for gastric cancer.Scientific reports · 2025Article
- Transcriptome and single-cell transcriptomics reveal prognostic value and potential mechanism of anoikis in skin cutaneous melanoma.Discover oncology · 2024Article
- The Silkworm Carboxypeptidase Inhibitor Prevents Gastric Cancer Cells' Proliferation through the EGF/EGFR Signaling Pathway.International journal of molecular sciences · 2023Article
- A novel treatment strategy for lapatinib resistance in a subset of HER2-amplified gastric cancer.BMC cancer · 2021Article
- Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies.Cell systems · 2018Article
- Cost-effectiveness of precision medicine in gastrointestinal stromal tumor and gastric adenocarcinoma.Journal of gastrointestinal oncology · 2017Review
- StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.Cancer medicine · 2017Article
- HER2-induced metastasis is mediated by AKT/JNK/EMT signaling pathway in gastric cancer.World journal of gastroenterology · 2016Article
- JWA down-regulates HER2 expression via c-Cbl and induces lapatinib resistance in human gastric cancer cells.Oncotarget · 2016Article
- The genomics and therapeutics of HER2-positive gastric cancer-from trastuzumab and beyond.Journal of gastrointestinal oncology · 2016Review
- Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation.Oncotarget · 2016Article
- Management and Mechanisms of Diarrhea Induced by Tyrosine Kinase Inhibitors in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer.Cancer control : journal of the Moffitt Cancer CenterReview
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.